Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWEET: Truvada vs Combivir Switch Study in HIV
NCT00323544Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2004
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Started Oct 2004; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00323544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323544.